Evidence map›Paper›PMID 14629620›Full record

ReviewScandinavian journal of immunology2003

T-helper cell tolerance to ubiquitous nuclear antigens.

B Nakken, K E Davis, Z J Pan, M Bachmann, A D Farris

Open access · bronzeAbstract readReview
In one paragraph

Review in Scandinavian journal of immunology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Extracellular vesicles extracted from young donor serum attenuate inflammaging via partially rejuvenating aged T-cell immunotolerance.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2018
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

B NakkenOklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA.
K E Davis
Z J Pan
M Bachmann
A D Farris
Oklahoma Medical Research Foundation · US

Funding

THROMBOCYTOPENIA AND THE GENETICS OF SEVERE LUPUSP50AR048940 · NIAMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI REICHLIN, MORRIS · 2002 to 2006
$5.8M
T cell to tolerance &autoimmunity to nuclear antigen LaR01AI048097 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI FARRIS, A DARISE · 2001 to 2012
$2.3M
Tolerance to the Nuclear Antigen LaK02AI051647 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI FARRIS, A. DARISE · 2002 to 2006
$484k
NIAID NIH HHS AI48097NIAID NIH HHS K02 AI051647NIAID NIH HHS K02 AI51647NIAID NIH HHS R01 AI048097NIAMS NIH HHS P50 AR048940NIAMS NIH HHS P50 AR48940
6 · The paper itself

Abstract

Systemic autoimmune diseases are characterized by the development of antinuclear autoantibodies. In order to understand the immunologic events leading to the development of such antibodies, knowledge of mechanisms of immune tolerance to nuclear antigens is required. By utilizing adoptive T-cell transfer strategies with transgenic mouse models expressing nuclear neo-self antigens, T-cell tolerance to the lupus-related nuclear antigens human La and nRNP A has been demonstrated. These findings also indicate the existence in normal animals of autoreactive B cells continuously presenting nuclear antigen, suggesting that nuclear antigens are not sequestered from the immune system. Investigations of CD4+ T-cell tolerance to non-nuclear antigens have revealed a number of mechanisms that protect the host from autoreactivity, including autoreactive T-cell deletion, regulatory T-cell development and anergy induction. Recent studies using T-cell receptor and neo-self nuclear antigen transgenic mice are revealing the importance of such mechanisms in maintaining tolerance to nuclear antigens. Mechanisms of tolerogenic antigen presentation, identification of tolerogenic antigen source(s) and the pathways leading to loss of tolerance to nuclear antigens in systemic autoimmune disease states are currently being sought.

Indexed as

Immune ToleranceAnimalsAntigen PresentationAntigens, NuclearApoptosisAutoimmune DiseasesHumansT-Lymphocytes, Helper-InducerAntigens, Nuclear

Identifiers

PMID14629620
PMCPMC2579760
OpenAlexW2147461388

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.